Challenges in Translating iPSC Technology
Dr. James Wells moderates a panel discussion on the biggest challenges in translating organoid-based cell therapies and the steps needed to bring these technologies to market in an efficient and patient-first manner.
Publish Date:
June 17, 2019
Views: 0
Related Multimedia
-
Potential Applications of ALDH Bright Cells In Regenerative Medicine
Publish Date: May 27, 2011 -
Modeling Human Gastrointestinal Development and Disease Using Pluripotent Stem Cells
Publish Date: March 06, 2017 -
CRISPR-Cas9 Gene Editing of Cerebral Organoids to Model Microcephaly
Publish Date: February 25, 2019
Explore Our Products
-
Cryopreserved mouse pancreatic exocrine organoids for establishment of organoid cultures -
STEMdiff™ Ventral Forebrain Organoid Differentiation Kit
Cell culture medium kit for robust generation of ventral forebrain neural organoids from human pluripotent stem cells -
Serum-free medium kit for the culture of kidney organoids from hPSCs -
IntestiCult™ Organoid Growth Medium (Mouse)
Cell culture medium for establishment and maintenance of mouse intestinal organoids
